Single dose treatment of vaginal candidosis: Randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis-Reference-Cited by-同舟云学术

Single dose treatment of vaginal candidosis: Randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis

Published:2009-04-24 Issue:1-2 Volume:34 Page:85-91
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:

Author:

Palacio A.,Sanz F.,Garcia-Bravo M.,Gimeno C.,Cuetara S.,Miranda P.,R-Noriega A.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1439-0507.1991.tb00624.x/fullpdf

Reference20 articles.

1. Antifungal activity in vitro of RO-14-4767/ 002, a phenylpropyl-morpholine;Polak;Sabouraudia,1983

2. Polak , A. Dixon , D. M. 1987 Antifungal activity of amo-rolfine (RO-14-4767/002) in vitro and in vivo Fromtling , R. A. Recent trends in the discovery, development and evaluation of antifungal agents 555 573

3. The effects of the morpholine derivative amorolfine (RO-14-4767/002) on the ultrastructure of Candida albicans;Müller;Mykosen,1987

4. Rhode , E. Zang , M. Hartmann , D. 1988 Preliminary clinical experience with RO-14-4767/002 (amorolfine) in superficial mycoses Fromtling , R. A. Recent trends in the discovery, development and evaluation of antifungal agents 575 582

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mejor coste-efectividad del tratamiento tópico de la onicomicosis leve-moderada con una aplicación semanal de amorolfina 5% que con dos aplicaciones semanales;Piel;2006-10

2. Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-releaseR cream (1, 2 and 4%) with placebo site-releaseR vaginal cream;Mycoses;2000-10-02

3. Amorolfine;Drugs;1995-01

4. Antifungal chemotherapy;Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques;1995

5. TOPICAL ANTIFUNGAL AGENTS;Obstetrics and Gynecology Clinics of North America;1992-09